vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and CSP INC (CSPI). Click either name above to swap in a different company.
AGIOS PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($20.0M vs $12.0M, roughly 1.7× CSP INC). CSP INC runs the higher net margin — 0.8% vs -541.1%, a 541.8% gap on every dollar of revenue. On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs -23.2%). CSP INC produced more free cash flow last quarter ($-3.0M vs $-97.3M). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs -6.3%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
CSP Inc. is a U.S.-based technology firm offering cybersecurity solutions, managed IT services, high-performance computing systems, and IT consulting support. It serves enterprises across healthcare, finance, manufacturing, and public sectors in North America and select global markets.
AGIO vs CSPI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $12.0M |
| Net Profit | $-108.0M | $91.0K |
| Gross Margin | 90.6% | 39.3% |
| Operating Margin | -608.9% | -0.9% |
| Net Margin | -541.1% | 0.8% |
| Revenue YoY | 86.1% | -23.2% |
| Net Profit YoY | -11.9% | -80.7% |
| EPS (diluted) | $-1.86 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.0M | $12.0M | ||
| Q3 25 | $12.9M | $14.5M | ||
| Q2 25 | $12.5M | $15.4M | ||
| Q1 25 | $8.7M | $13.1M | ||
| Q4 24 | $10.7M | $15.7M | ||
| Q3 24 | $9.0M | $13.0M | ||
| Q2 24 | $8.6M | $13.1M | ||
| Q1 24 | $8.2M | $13.7M |
| Q4 25 | $-108.0M | $91.0K | ||
| Q3 25 | $-103.4M | $-191.0K | ||
| Q2 25 | $-112.0M | $-264.0K | ||
| Q1 25 | $-89.3M | $-108.0K | ||
| Q4 24 | $-96.5M | $472.0K | ||
| Q3 24 | $947.9M | $-1.7M | ||
| Q2 24 | $-96.1M | $-185.0K | ||
| Q1 24 | $-81.5M | $1.6M |
| Q4 25 | 90.6% | 39.3% | ||
| Q3 25 | 87.0% | 36.6% | ||
| Q2 25 | 86.3% | 28.8% | ||
| Q1 25 | 87.6% | 32.0% | ||
| Q4 24 | 88.3% | 29.1% | ||
| Q3 24 | 91.3% | 28.4% | ||
| Q2 24 | 82.6% | 35.0% | ||
| Q1 24 | 92.3% | 47.3% |
| Q4 25 | -608.9% | -0.9% | ||
| Q3 25 | -907.4% | -3.7% | ||
| Q2 25 | -1020.1% | -7.9% | ||
| Q1 25 | -1222.0% | -7.6% | ||
| Q4 24 | -1165.3% | -2.3% | ||
| Q3 24 | -1146.9% | -15.7% | ||
| Q2 24 | -1228.3% | -5.5% | ||
| Q1 24 | -1124.3% | 9.0% |
| Q4 25 | -541.1% | 0.8% | ||
| Q3 25 | -803.1% | -1.3% | ||
| Q2 25 | -899.4% | -1.7% | ||
| Q1 25 | -1023.3% | -0.8% | ||
| Q4 24 | -899.6% | 3.0% | ||
| Q3 24 | 10574.7% | -12.7% | ||
| Q2 24 | -1115.7% | -1.4% | ||
| Q1 24 | -995.8% | 11.6% |
| Q4 25 | $-1.86 | $0.01 | ||
| Q3 25 | $-1.78 | $-0.02 | ||
| Q2 25 | $-1.93 | $-0.03 | ||
| Q1 25 | $-1.55 | $-0.01 | ||
| Q4 24 | $-1.44 | $0.05 | ||
| Q3 24 | $16.22 | $-0.17 | ||
| Q2 24 | $-1.69 | $-0.02 | ||
| Q1 24 | $-1.45 | $0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | $24.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $44.8M |
| Total Assets | $1.3B | $69.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.1M | $24.9M | ||
| Q3 25 | $92.7M | $27.4M | ||
| Q2 25 | $80.9M | $26.3M | ||
| Q1 25 | $79.0M | $29.5M | ||
| Q4 24 | $76.2M | $30.7M | ||
| Q3 24 | $253.7M | $30.6M | ||
| Q2 24 | $84.5M | $28.9M | ||
| Q1 24 | $118.8M | $27.1M |
| Q4 25 | $1.2B | $44.8M | ||
| Q3 25 | $1.3B | $44.6M | ||
| Q2 25 | $1.4B | $47.5M | ||
| Q1 25 | $1.5B | $47.5M | ||
| Q4 24 | $1.5B | $47.5M | ||
| Q3 24 | $1.6B | $47.3M | ||
| Q2 24 | $660.5M | $48.1M | ||
| Q1 24 | $743.9M | $48.2M |
| Q4 25 | $1.3B | $69.2M | ||
| Q3 25 | $1.4B | $71.2M | ||
| Q2 25 | $1.5B | $66.8M | ||
| Q1 25 | $1.6B | $67.1M | ||
| Q4 24 | $1.7B | $67.5M | ||
| Q3 24 | $1.8B | $69.4M | ||
| Q2 24 | $773.1M | $66.8M | ||
| Q1 24 | $849.7M | $64.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | $-2.9M |
| Free Cash FlowOCF − Capex | $-97.3M | $-3.0M |
| FCF MarginFCF / Revenue | -487.5% | -25.1% |
| Capex IntensityCapex / Revenue | 5.6% | 0.9% |
| Cash ConversionOCF / Net Profit | — | -32.04× |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | $-2.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.2M | $-2.9M | ||
| Q3 25 | $-88.2M | $1.9M | ||
| Q2 25 | $-77.1M | $-3.3M | ||
| Q1 25 | $-111.5M | $1.9M | ||
| Q4 24 | $-133.2M | $1.7M | ||
| Q3 24 | $-84.2M | $-1.5M | ||
| Q2 24 | $-72.6M | $2.4M | ||
| Q1 24 | $-99.9M | $1.7M |
| Q4 25 | $-97.3M | $-3.0M | ||
| Q3 25 | $-89.7M | $1.7M | ||
| Q2 25 | $-78.0M | $-3.3M | ||
| Q1 25 | $-112.3M | $1.9M | ||
| Q4 24 | $-134.1M | $1.7M | ||
| Q3 24 | $-84.6M | $-1.5M | ||
| Q2 24 | $-72.7M | $2.4M | ||
| Q1 24 | $-100.0M | $1.6M |
| Q4 25 | -487.5% | -25.1% | ||
| Q3 25 | -696.5% | 11.5% | ||
| Q2 25 | -626.2% | -21.7% | ||
| Q1 25 | -1286.4% | 14.5% | ||
| Q4 24 | -1250.1% | 10.8% | ||
| Q3 24 | -944.2% | -11.7% | ||
| Q2 24 | -844.4% | 17.9% | ||
| Q1 24 | -1221.2% | 11.9% |
| Q4 25 | 5.6% | 0.9% | ||
| Q3 25 | 12.1% | 1.6% | ||
| Q2 25 | 7.0% | 0.4% | ||
| Q1 25 | 8.8% | 0.1% | ||
| Q4 24 | 9.0% | 0.3% | ||
| Q3 24 | 4.7% | 0.1% | ||
| Q2 24 | 1.8% | 0.3% | ||
| Q1 24 | 1.7% | 0.1% |
| Q4 25 | — | -32.04× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.69× | ||
| Q3 24 | -0.09× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGIO
Segment breakdown not available.
CSPI
| Products | $6.7M | 56% |
| Services | $5.3M | 44% |
